Meghan Duncan

Associate Director, Clinical Operations at Xilio Therapeutics - Waltham, MA, US

Meghan Duncan's Contact Details
HQ
617-430-4762
Location
Greater Boston Area
Company
Xilio Therapeutics
Meghan Duncan's Company Details
Xilio Therapeutics logo, Xilio Therapeutics contact details

Xilio Therapeutics

Waltham, MA, US • 100 - 249 Employees
BioTech/Drugs

Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company's proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. To learn more, please visit www.xiliotx.com.

N/A
Details about Xilio Therapeutics
Frequently Asked Questions about Meghan Duncan
Meghan Duncan currently works for Xilio Therapeutics.
Meghan Duncan's role at Xilio Therapeutics is Associate Director, Clinical Operations.
Meghan Duncan's email address is ***@xiliotx.com. To view Meghan Duncan's full email address, please signup to ConnectPlex.
Meghan Duncan works in the BioTech/Drugs industry.
Meghan Duncan's colleagues at Xilio Therapeutics are Bernard Lanter, Brian Ames, Patrick Fredericksen, Justin Greene, Joseph C., Parker Johnson, Kyle Smith and others.
Meghan Duncan's phone number is 617-430-4762
See more information about Meghan Duncan